Journal of Visualized Experiments

O_LIThe effect of some bioactive compounds on living organisms is dependent on their concentration and gradients, as is the case of hormones and signalling peptides, determining cell identity, activity and organism development. C_LIO_LIThere are a handful of methods that allow to produce spatially confined peaks of concentration local application of biochemicals on plants, such as agar blocks and microinjection, but they lack in precision, throughput and/or simplicity. C_LIO_LIWe developed the MicroTron, a microfluidics-based method specifically for filamentous organisms or life cycle stages, like the moss plant Physcomitrium patens protonemata, that serves as a platform for the application of chemicals on single cells and study the cell response. C_LIO_LIWe show how chemical applications could be performed on cells, either on the side or apically with dyes and hormones, targeting the cell wall, cell membrane, cytosol and nucleus. C_LIO_LITreatments could be applied on single filaments and with a precision of up to single cells in optimal conditions. C_LIO_LIThis method could be used to study live responses to chemicals with high spatiotemporal resolution. C_LI

Apolipoprotein E (ApoE) is the strongest genetic predictor of Alzheimers disease (AD) risk, with ApoE4 increasing and ApoE2 decreasing risk relative to ApoE3. Using a global LC-MS proteomic approach, we integrated protein abundance and kinetics in Human-APOE knock-in mice for young (3-month) and aged (18-month) cohorts to quantify the changes in steady-state proteostasis. By mapping 6,052 identified proteins and 3,986 associated turnover rates into ontological groups, we observed that vesicle trafficking and mitochondrial dysregulation occur as early as 3 months in ApoE4 mice accompanied by hyperactive metabolism that eventually reduces with age. In contrast, young and old ApoE2 mice retain similar signatures to ApoE3 mice in metabolic, mitochondrial, cellular regulation, and membrane trafficking ontologies. We found that females had more isoform-induced ontological changes relative to ApoE3, providing insight into sex-dependent vulnerabilities. Our global proteomic approach for ApoE proteostasis crucially unifies independent literature observations while providing turnover kinetics to uncover the underlying mechanism behind abundance changes. Data are available via ProteomeXchange with identifier PXD079261. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=189 SRC="FIGDIR/small/735293v1_ufig2.gif" ALT="Figure 1000"> View larger version (45K): org.highwire.dtl.DTLVardef@54c14borg.highwire.dtl.DTLVardef@5e490dorg.highwire.dtl.DTLVardef@df5b1org.highwire.dtl.DTLVardef@7d7717_HPS_FORMAT_FIGEXP M_FIG C_FIG O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=139 SRC="FIGDIR/small/735293v1_ufig1.gif" ALT="Figure 1001"> View larger version (48K): org.highwire.dtl.DTLVardef@115c4cdorg.highwire.dtl.DTLVardef@2baac8org.highwire.dtl.DTLVardef@d965e6org.highwire.dtl.DTLVardef@b0e49a_HPS_FORMAT_FIGEXP M_FIG C_FIG

This step-by-step protocol provides a cross-species, non-surgical approach that enables prenatal gene delivery to the developing nervous system in rats and marmosets. Under transabdominal ultrasound guidance, intracerebroventricular injection of recombinant adeno-associated virus vectors into the fetal brain achieves robust and long-term transduction from prenatal stages into adulthood. This approach can be adapted to other species and target sites outside nervous system, enabling safe and selective intrauterine manipulation and the generation of diverse experimental models for basic and preclinical research. For complete details on the use and execution of this protocol, please refer to Ribeiro Gomes et al (2026)1. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=181 SRC="FIGDIR/small/737050v1_ufig1.gif" ALT="Figure 1"> View larger version (47K): org.highwire.dtl.DTLVardef@696364org.highwire.dtl.DTLVardef@fc3c7forg.highwire.dtl.DTLVardef@1e7c7caorg.highwire.dtl.DTLVardef@1edcef0_HPS_FORMAT_FIGEXP M_FIG C_FIG Before you beginExperimental procedures during gestation allow researchers to study developmental processes, including how manipulations of the fetus and its intrauterine environment influence biological outcomes. Ultrasound imaging guidance greatly facilitates such interventions by providing safe and targeted access to fetal compartments, including for prenatal gene delivery to developing neural cell populations. Critically, delivery of recombinant adeno-associated viruses (rAAVs) into the cerebrospinal fluid (CSF) of developing animals enables widespread gene transfer across the brain. The efficiency and distribution of transduction are strongly influenced by developmental stage, making the timing of delivery an important experimental variable. In altricial species such as mice, major developmental processes, including cortical lamination and the establishment of long-range connections, begin prenatally but continue throughout early postnatal life. In primates, however, development is more advanced at birth, and many equivalent developmental events are shifted to the prenatal period. Consequently, developmental stages that can be targeted postnatally in mice require prenatal access in primates. Here, we present a step-by-step protocol for ultrasound-guided fetal intracerebroventricular viral injection (FIVI) of rAAV in marmosets (Callithrix jacchus) and rats (Rattus norvegicus). The procedure was initially developed and optimized in rats before being translated to marmosets, small New World primates that share key developmental, anatomical, and functional characteristics with humans. Together, these models illustrate the cross-species applicability of the approach, while providing gene delivery strategies for both a genetically tractable rodent model and a translationally relevant nonhuman primate. FIVI enables broad gene transfer and stable, long-term transgene expression in wild type animals, facilitating the generation of complementary quasi-transgenic models for research and translational applications from prenatal development through adulthood.

Background. Scanning electron microscopy (SEM) is widely used to determine fibrin fiber structural properties such as fiber diameter and fiber length. However, conventional SEM preparation protocols are time-consuming and typically require conductive sputter coating. The coating process introduces an additional layer onto the sample surface and may influence measurements of nanoscale fiber structure. Furthermore, preparation of purified fibrinogen clots often follows protocols originally developed for plasma clots, resulting in unnecessary processing steps. Objective. To evaluate indium tin oxide (ITO) as a flat, conductive substrate for SEM imaging of fibrin fibers, investigate the effects of sputter coating on measured fiber diameter, and develop a simplified SEM preparation protocol for purified fibrinogen clots. Methods. Platelet-poor plasma clots and purified fibrinogen clots were formed on ITO substrates and imaged by SEM following 0 s, 45 s, or 90 s sputter coating. Fibrin fiber diameters were quantified and compared across coating conditions. For purified fibrinogen clots, an ITO-based simplified preparation protocol, in which clots were formed and imaged directly on the conductive ITO surface, was compared with a previously developed, standardized SEM protocol, in which clots were formed in microtube lids and subsequently transferred onto carbon tape for imaging. Results. Fiber diameter measurements were affected by sputter coating duration, with increasing coating time resulting in larger apparent fiber diameters. Plasma and purified fibrinogen clots exhibited distinct fiber diameter distributions and coating responses. For purified fibrinogen clots, the simplified ITO-based protocol produced fiber diameter measurements that were not significantly different from those obtained using the standardized lid-to-carbon-tape workflow when identical coating times were applied. Conclusions. ITO provides a practical conductive substrate for SEM imaging of fibrin fibers and enables substantial simplification of purified fibrinogen clot preparation. When coating conditions are matched, the simplified ITO-based protocol yields fiber diameter measurements comparable to those obtained using the previously standardized lid-to-carbon-tape workflow. These findings support the use of ITO as an alternative conductive imaging substrate and provide a simplified workflow for SEM analysis of purified fibrinogen clots. By reducing washing and transfer steps, this workflow may also provide a useful platform for future controlled studies of fibrin interactions with added proteins or other associated components.

Introduction: Acute compartment syndrome (ACS) is a limb-threatening complication of extremity trauma that requires timely diagnosis to prevent irreversible muscle and nerve injury. Current diagnostic methods are invasive, intermittent, and operator-dependent. We evaluated the feasibility of a novel, Bluetooth-enabled electrical impedance myography (EIM) device (mAlert, Myolex, Inc., Brookline, MA, USA) for continuous, noninvasive detection of ACS-related tissue changes. Methods: Ten Yorkshire swine underwent anterior tibial compartment monitoring using three ACS models: albumin infusion (ALB, n=3), femoral artery and vein ligation (LIG, n=3), and combined albumin infusion plus ligation (ALB+LIG, n=4). Resistance (R), reactance (X), and phase (P) were measured every minute across 1 to 199 kHz alongside continuous intra-compartmental pressure (ICP) monitoring. Group differences in normalized impedance trends were evaluated using the Kruskal Wallis test with Dunn post hoc correction. As a proof-of-concept human study, nine healthy volunteers wore the device for up to five days to assess electrode durability and signal stability. Tissue ischemia was validated using pimonidazole immunohistochemistry. Results: ALB infusion produced progressive, frequency-dependent decreases in R, X, and P, whereas LIG produced consistent increases in R and X across frequencies. The ALB+LIG model generated mixed responses, reflecting the competing effects of edema and ischemia. Normalized phase slopes differed significantly among groups (H=6.14, p=0.046), with post hoc testing showing significant divergence between the ALB and LIG models (p=0.041). Control limbs remained stable throughout monitoring. Pimonidazole staining confirmed hypoxic injury in the intervention limb. In the human pilot study, three participants completed five days of monitoring, demonstrating sustained signal acquisition, while electrode degradation limited data collection in the remaining participants. Conclusions: This preliminary feasibility study demonstrates that wearable EIM can continuously detect model-specific physiological changes associated with ACS in a large-animal model. These findings support further development and clinical evaluation of wearable EIM as a non-invasive monitoring technology for early ACS detection in trauma patients.

A major challenge in behavioral neuroscience is the lack of a unified software framework capable of implementing diverse paradigms across species and experimental setups. Researchers currently face a trade-off: they must either spend significant time developing custom, siloed solutions that hinder reproducibility, or incur substantial costs purchasing inflexible, closed systems. Here, we present Neurokraken, an open-source, Python-native platform designed to overcome these limitations. Neurokraken allows writing experiment progression entirely in standard python, while its core architecture automatically sets up a microcontroller for the connected hardware components and enables python side access with millisecond-precision timing and automatic logging. The system prioritizes ease of use and flexibility, enabling advanced series of events and conditions, the usage of python ecosystem code and packages within experiments, and the addition of any arduino-compatible electronic devices for custom experiments. As a result, users can easily create interactive virtual and real environments to engage, monitor, and record subjects. We present Neurokraken's versatility across a wide range of paradigms, for human and non-human primate psychophysics, and complex rodent behavior in both head-fixed and freely moving paradigms. Its modular design allows for rapid hardware reconfiguration, while a fully customizable user interface enables real-time monitoring and interactive experimental control without compromising timing precision. By uniting laboratory-grade precision with an accessible and flexible open-source philosophy, Neurokraken provides a single, powerful solution to design and execute next-generation behavioral experiments. We hope Neurokraken helps accelerate research, improve reproducibility throughout the neuroscience community, and make advanced behavioral experimentation more accessible through its substantial cost-efficiency.

Plasma membrane sheets generated by controlled mechanical disruption provide direct access to the cytosolic face of the plasma membrane while preserving the native organization of membrane-associated proteins and lipids. Here, we present a protocol for generating and validating sonication-derived plasma membrane sheets from cultured cells, primary neurons, and isolated synaptosomes. We further describe their application for live and fixed imaging of membrane protein localization, organization, conformational dynamics, and protein-protein interactions, as well as quantitative membrane-associated synaptic vesicle recruitment assays. This versatile platform preserves the native membrane environment while enabling direct visualization and quantitative analysis of membrane-associated processes at high spatial resolution. The protocol can be readily adapted to investigate diverse membrane proteins, lipid-dependent mechanisms, and vesicle tethering events across a wide range of cellular systems.

Chemical imaging is a powerful branch of modern microscopy encumbered by a lack of flexible, high-throughput analysis tools. Bespoke analytical pipelines typically perform ratiometric analysis on two layers in a multispectral image to describe the relative composition of molecules in a sample. This strategy has been implemented across fields, spanning histopathology, cell biology, environmental science, and materials science. The commercialization of chemical imaging microscopes has facilitated the collection of large multispectral datasets, necessitating accessible ways to process them. This paper describes Multispectral Analysis Graphical User Interface (msaGUI), a desktop graphical user interface to analyze individual and batch datasets of multispectral images. Data is loaded as CSV, TSV, or TIFFs and processed through a user-defined sequence of modular image operations that can be flexibly combined, e.g. to reduce spectral crosstalk or background noise. After analysis, data is visualized as exportable images, histograms, and statistics. To yield publication-quality figures, outputted images are fully customizable. Written in Python with open-source libraries, the msaGUI program is packaged into an executable for Windows and Mac for a fully no-code application. Other operating systems are supported via the Python source code. In summary, msaGUI provides a rapid and user-friendly solution for analyzing and visualizing multispectral data.

Fluorescence correlation spectroscopy (FCS) provides valuable information about molecular dynamics, however, experimental setup typically requires labour-intensive passivation to prevent non-specific binding of molecules to sample containers. Furthermore, precious samples can be wasted by having to use relatively high sample volumes in existing sample containers. We overcome these major issues using a simple method of sample encapsulation into water-in-oil droplets, using purified proteins and cell lysates as proof-of-concept. FCS of fluorescently labelled protein samples in the nanomolar (nM) range confirmed that water-in-oil droplets yield more accurate measurements than conventional open-chamber methods. We first optimized the droplet composition to prevent protein coating at the water-oil interface using pegylated-lipids. We then utilized FCS to accurately measure protein concentrations and diffusion speeds in nanolitre volumes. Additionally, we used fluorescence cross-correlation spectroscopy (FCCS) to measure enzymatic cleavage of substrate inside our droplet system, demonstrating the capacity of this platform to measure biological processes at the nanoscale. Overall, conducting FCS in droplets offers a cost-effective, robust, and accessible alternative for measuring molecular dynamics, with promising potential for high-throughput and resource-limited applications. TOC Image + Text O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=37 SRC="FIGDIR/small/734730v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@e0023dorg.highwire.dtl.DTLVardef@b32cb0org.highwire.dtl.DTLVardef@13ad832org.highwire.dtl.DTLVardef@47dc12_HPS_FORMAT_FIGEXP M_FIG C_FIG Conventional single-molecule fluorescence requires slow, expensive glass passivation procedures to prevent proteins adsorbing to surfaces. By encapsulating proteins in lipid-coated nanolitre water droplets, the passivation requirement is removed, enabling accurate measurement of protein dynamics in low nanolitre volumes. Water-in-oil droplets thus provide a passivation-free platform for fluorescence correlation spectroscopy.

When autopsy findings are presented on two-dimensional paper-based models, there is an inherent reduction of spatial information, which the viewer must infer from simplified anatomical and geometrical representations. Multiple diagrams representing trajectory angles must be integrated into a complete mental model, introducing potential for errors in viewer understanding. 3D models can address these issues but have shown limited adoption in forensic autopsy reporting given the technical competences and software required to produce them. Here, we present AutopsyPrint, a workflow and open web-based tool for generating 3D printable body models annotated with wound trajectories. The tool supports marking different wound types, including ballistic and stab wounds, on male and female bodies, which can be posed to accommodate a diversity of trajectories. Based on our testing, we present a set of suggested workflow steps and parameters based to facilitate standardization of the 3D models produced, balancing between precision and print time and materials. To ensure accessibility, the tool runs fully in the user's browser, and all annotated data is stored locally. By making AutopsyPrint open access, we intend to build practical experience with model creation, to ultimately advance the use of 3D models in the field.

ObjectiveTo investigate and clarify the role of Ginsenoside Ro (GRo) in diabetic cardiomyopathy (DiaCM) and to elucidate the molecular mechanism by which GRo ameliorates DiaCM. Methods[circled1] The construct of type 2 diabetic mouse model. The bought C57BL/6 male mice were housed in a specific pathogen-free (SPF) animal facility and randomly divided into control, STZ (model), STZ + GRo, and control+GRo groups. The STZ (model) and STZ + GRo groups were fed a high-fat and high-glucose diet combined with intraperitoneal injection of streptozotocin (STZ). The control and control + GRo groups were fed a normal diet, while the control + GRo and STZ + GRo groups were treated with GRo via oral gavage. Then, all groups were evaluated for cardiac function and structure by small animal echocardiography and histological staining including hematoxylin and eosin (HE) and Massons trichrome staining to screen and confirm diabetic cardiomyopathy in mice. Finally, immunofluorescence staining of cilia in mouse heart tissue was performed to determine whether GRo inhibits abnormal ciliary growth. [circled2] The construct of cell models. First, the CCK-8 (Cell Counting Kit-8) assay was used to separately evaluate the cytotoxicity of GRo and the combination of TGF-{beta}1 and PA in myocardial fibroblasts and cardiomyocytes. Subsequently, mouse myocardial fibroblast lines (MCFs) were treated with transforming growth factor-beta 1 (TGF-{beta}1), and H9c2 cardiomyocytes were treated with palmitic acid (PA). Both cell types then received the GRo treatment. [circled3] Molecular and cellular testing. Firstly, we measured serum levels of cardiac injury markers (CK-MB, MYO, and TNNI3), glutathione (GSH), and malondialdehyde (MDA). Secondly, we examined the expression of myocardial fibrosis-related genes (Col1a1, etc.), myocardial hypertrophy markers (Nppa, etc.), cilia-specific genes (Pkd1, etc.), and oxidative stress-related genes (Nrf2, etc.) in both animal and cell samples by Western blotting and RT-qPCR. Finally, we used immunofluorescence staining of myocardial fibroblasts to detect cilia length and phalloidin staining of cardiomyocytes to measure their cross-sectional area. [circled4] The correlation mechanism. Firstly, the cilia-specific inhibitory drug HIP-4 was used to disrupt cilia homeostasis by inhibiting cilia growth. Secondly, small activating RNA (saRNA) was used to upregulate the Pkd1 gene to verify whether GRo exerts its anti-fibrotic effects through the inhibition of PC1. Results[circled1] Animal level. A diabetic cardiomyopathy mouse model was successfully established by combining STZ injection with a high-fat and high-glucose diet, and treatment with GRo significantly ameliorated the associated symptoms. [circled2] Cellular level. We successfully established a myocardial fibrosis model by treating myocardial fibroblasts with TGF-{beta}1, and a myocardial hypertrophy model by treating cardiomyocytes with PA. Immunofluorescence staining demonstrated that GRo significantly decreased cilia length in the fibrosis model, while phalloidin staining showed that GRo significantly attenuated the increase in cardiomyocyte cross-sectional area. [circled3] Molecular level. Compared with the model group, GRo treatment significantly reduced serum levels of cardiac injury markers (CK-MB, MYO and TNNI3), glutathione (GSH) and malondialdehyde (MDA). Western blotting and RT-qPCR analyses of both animal and cell samples revealed that GRo markedly alleviated indicators of myocardial fibrosis and hypertrophy, while also suppressing cilia-specific genes and oxidative stress-related genes. Overall, GRo significantly ameliorated the markers associated with myocardial fibrosis and hypertrophy, and inhibited cilia-specific protein expression as well as oxidative stress parameters. [circled4] The correlation mechanism. The cilia-specific drug hedgehog pathway inhibitor 4 (HPI-4) was used to revealed that cilia homeostasis is closely linked to myocardial fibrosis and shortened cilia inhibit the fibrosis progression. Furthermore, upregulation of the Pkd1 gene by small activating RNA demonstrated that PC1 overexpression abrogates the therapeutic effect of GRo. Finally, GRo can alleviate DiaCM.

The COVID-19 pandemic has imposed a reevaluation of safety protocols across various sectors, including the arts. This study addresses a critical gap in understanding SARS-CoV-2 persistence on materials commonly associated with musical instruments and scores, such as alloys, varnishes, reeds, and paper. While previous research has explored viral survival on various surfaces, limited data exists for materials specific to musical contexts. In this work, we investigate the efficacy of quarantine as a non-destructive method for inactivating SARS-CoV-2 on 16 materials, including brass, silver plating, ABS plastic, ebonite, and various varnishes and paper types. Results revealed significant variability in viral persistence across materials. Non-porous surfaces like metals and ABS plastic cleared infectivity within 3 days, while porous materials such as reeds and music scores required up to 7 days. Gold-plated brass and certain varnishes showed intermediate persistence, with infectivity clearing after 4 days. These findings are in agreement with prior studies indicating that SARS-CoV-2 survival is highly dependent on surface composition, with porous and organic-coated materials retaining viable virus longer due to reduced environmental stress. Our results highlight the feasibility of stratified quarantine protocols based on material type, offering practical guidelines for musicians and institutions and provides critical insights for mitigating SARS-CoV-2 transmission risks in musical settings.

Joint music making offers an ecologically powerful framework for investigating human social interaction and synchronization. Yet, experimental paradigms often rely on traditional instruments that limit accessibility, reproducibility, and experimental control. In parallel, the use of music for therapy and rehabilitation is expanding, motivating the development of digital musical instruments that can serve research, educational, and clinical purposes. Here, we introduce the e-Music Box Roma (eMB Roma), an open, reproducible digital musical instrument designed to study music making behavior regardless of musical training. The eMB Roma plays preregistered music with tempo controlled by hand rotary movements. Building on the original e-Music Box (Novembre et al., 2015), the eMB Roma retains its intuitive rotary hand control while introducing major innovations: a fully open and 3D-printable design, modular hardware with integrated slider and button controls, polyphonic output with multiple simultaneous instruments, and MIDI compatibility. Additionally, a dedicated graphical user interface allows real-time monitoring, experiment control, device synchronization (like neuroimaging or motion capture devices), and both solo and joint music-making paradigms. The eMB Roma provides a flexible and accessible platform for research contexts, allowing experimental control, reproducibility, and future extensions. Its open design and modularity make it suitable not only for research but also for therapeutic, rehabilitation, and educational applications, where it can support personalized interventions and quantitative assessment of motor performance.

Low-cost and open-source neural recording systems are increasingly important for expanding access to electrophysiological research. However, many existing platforms still rely on specialized hardware or limited modularity, restricting flexibility for laboratories seeking customizable solutions. Here, we developed and evaluated a modular neural recording platform constructed entirely from commercially available components. Recordings were compared against the ground truth. The platform successfully recovered local field potential (LFP)-like waveforms in most conditions and detected spike-like activity during direct connection recordings. Principal component analysis and k-means clustering further demonstrated the ability to distinguish multiple simulated spike waveforms. Signal quality varied across configurations, with saline recordings and preamplifier integration introducing increased noise and reduced detectability. These findings demonstrate the feasibility of building affordable and modular electrophysiology systems using widely accessible hardware. Although the current implementation has limitations in sampling rate, noise performance, and in vivo validation, the presented framework provides a practical foundation for future customizable open-source neural recording.

A test technique for measuring high-frequency transient current components in deep brain tissue is presented. The technique applies a voltage pulse with a high value in dV/dt, generating a corresponding current pulse with high dI/dt that can elicit measurable transient current responses from the electrode/tissue interface and adjacent brain tissue; responses are analyzed in the frequency domain by Fast Fourier Transform at a 200 kHz sampling frequency. The method was motivated by prior evidence that ferritin and neuromelanin in catecholaminergic tissue may support high-frequency conduction properties that have not previously been characterized in vivo. The protocol was applied in 277 measurements across five Sprague Dawley rats at cortical and basal ganglia locations in different locations in the brain. Preliminary spectral results show differences between catecholaminergic regions and cortical tissue that support further development and validation of the method.

ObjectiveThe Lab Streaming Layer (LSL) protocol, widely adopted for synchronized multimodal biosignal recording in neuroscience research, transmits all data in plaintext, exposing sensitive neural and physiological recordings to interception and tampering and creating regulatory liability for clinical and commercial deployments across most major international jurisdictions. We present Secure LSL, the unified encryption architecture for the protocol: a novel security layer that authenticates devices and encrypts biosignal streams through transparent, drop-in modifications to the core library, requiring no application changes and no recompilation for dynamically linked clients. ApproachWe implement encryption at the liblsl core library level using a shared keypair authorization model with ChaCha20-Poly1305 authenticated encryption. All authorized devices share a common Ed25519 keypair, and public key verification during connection establishment ensures only authorized devices communicate. The architecture enforces network-wide security consensus, requiring all connected devices to operate in either secure or insecure mode, eliminating vulnerable mixed environments, and operates transparently with zero code changes to existing applications. Main ResultsThe architecture preserves application programming interface (API) transparency, so existing applications need no code changes (legacy devices must update to connect to secured outlets). Across five hardware platforms spanning x86 desktop, Apple Silicon laptop, embedded ARM single-board, and Xtensa microcontroller targets, encryption adds sub-millisecond latency in all desktop and embedded ARM configurations, with overhead in the single-digit percent range (approximately 4 to 9%, the lowest values within measurement noise of zero) for typical 64-channel, 1000-Hz configurations. A clean-room ESP32 implementation extends transparent encryption to dual-core microcontrollers with no measurable push-path overhead and approximately 2 kB additional static random-access memory (SRAM) consumption, enabling secured wearable and ambulatory biosensor deployments. SignificanceBy implementing security within the protocol core rather than requiring application-level changes, we transform LSL from a research-only protocol to a security-capable platform for clinical settings, multi-institution collaborations, and commercial products, while preserving its zero-configuration philosophy.

Existing interfaces modulate user experience through visual, auditory, and haptic channels, but direct physiological modulation, which programmatically alters a user's internal state, remains largely underexplored. We present a wearable sonophoresis patch that uses low-frequency acoustic stimulation to deliver psychoactive substances transdermally, and evaluate its potential for programmable physiological modulation in HCI. We tested this in a double-blinded study (N=26) delivering 100 mg caffeine versus sham control, recording physiological signals during rest and a sustained attention task (SART). The planned comparison for heart rate standard deviation during rest was significant (HR-SD p=0.025, d=1.48), with the caffeine group showing suppressed HR~SD consistent with sympathetic activation. Mean heart rate at rest was not significant (p=0.365), but exploratory analyses during the cognitive task revealed significant cardiovascular divergence: heart rate (p=0.003) and heart rate standard deviation (p=0.027) both moved in directions consistent with systemic caffeine delivery, with effects emerging within minutes of device activation and a sustained group effect across all task rounds (p<0.001). These results provide indirect evidence that wearable sonophoresis can deliver substances to modulate user physiology, opening the design space for on-skin chemical interfaces that adapt delivery in real time to change the user's physiological state on demand.

BackgroundConventional rodent models for the study of corneal pain commonly evoke eye blink reflex using methods that indiscriminately activate polymodal nociceptors, mechanoreceptors, and thermoreceptors at temporal resolutions that dont closely match the sub-second timescale of underlying neural dynamics. New methodWe introduce a novel automated behavioral paradigm for detecting blink reflexes in transgenic TRPV1-ChR2-EYFP mice, enabled by cell-type-specific, millisecond-precision optogenetic stimulation of corneal nociceptors (490 nm light). Using multi-feature quantification, we achieve robust automated detection using univariate and multivariate classifiers. ResultsTRPV1-ChR2-EYFP mice exhibited blink reflexes to high-intensity blue light (490 nm, 10 ms pulses) in a threshold-dependent manner (N=3). Blink probability was 77.1 {+/-} 17.1% at high intensity (2.77 mW/mm2) versus 4.2 {+/-} 4.2% at low intensity (0.46 mW/mm2). Red light (638 nm) produced no intensity-dependent change. Noxious air puff evoked blinks in >95% of trials under all conditions. DeepLabCut-based pose estimation extracted six features quantifying the blink reflex, enabling automated detection with [&ge;]98% accuracy using univariate and multivariate classifiers. Comparison with existing methodsUnlike conventional air puff paradigms, this optogenetic approach enables precise, cell-type-specific stimulation of corneal nociceptors, supporting automated analysis of blink responses at sub-second resolution. ConclusionsThis video tracking behavioral method using machine learning algorithms that accurately classify blink versus no-blink enables high-throughput and observer-independent empirical assessment of blink reflex, suggestive of corneal pain. Moreover, inducing blink reflex in TRPV1-ChR2 mice using high-intensity blue light also demonstrates nociceptive-specific behavioral responses analogous to somatosensory optogenetically-evoked hindpaw pain in the same animal genotype.

Chimeric antigen receptor (CAR)-T cell therapies have transformed the treatment of various tumor types by redirecting and activating T cells against tumor cells. However, CAR-T cell manufacturing approaches remain challenging and limit their widespread use in clinical settings. In vivo CAR-T therapy bypasses ex vivo cell manufacturing and patient preconditioning limitations; however, it faces a significant safety concern as CAR proteins on viral packaging cells are incorporated into budding virions, leading to off-target transduction of tumor cells. Here, we address this risk by developing the CAR-Less ER-Anchor Vector (CLEAN-V) system. By exploiting endoplasmic reticulum (ER) retention, CLEAN-V prevents the CAR protein from trafficking to the cell surface during viral packaging, thereby blocking its incorporation into the viral envelope. CLEAN-V particles exhibit near-complete loss of CAR-mediated tumor cell transduction. Furthermore, CLEAN-V integrates seamlessly into existing third-generation LVV workflows in four- or five-plasmid formats and generates CAR-T cells with preserved phenotypic and functional integrity. These results establish CLEAN-V as a robust platform for developing safe, targeted lentiviral vectors for in vivo CAR-T therapy.

A multi-omic approach utilizing a single biospecimen is important to avoid intra-sample heterogeneity associated with testing multiple omic single-samples, and for more efficient use of small volumes of precious biopsies (<30 mg). This is especially true for the microanatomy of post-mortem human brain samples. Using post-mortem human brain biospecimens from the NIH NeuroBioBank, a penta-omic sequential extraction method is described, Simultaneous Metabolomic, Proteomic, Lipidomic - DNA, RNA Extraction (SiMPL-DREx). Each sequential omic extract was compared to those obtained by the gold standard single omic method. Preserving RIN is critical for brain and tissue banks, as it is a primary measure of tissue quality. For all five omic extracts, the tissue integrity numbers and omic profiles did not significantly differ from those obtained by the respective omic gold standard method. Unlike past multi-omic studies, this study quantified the relative solvent percentages and upstream losses for both the organic and aqueous phases, confirming an omics loss of under 5%.